Diffuse Large B-Cell Lymphoma Untreated | Mantle cell lymphoma Untreated | Follicular Lymphoma Grade Untreated | Burkitt Lymphoma Untreated | Peripheral T-Cell Lymphoma Untreated | NK/T-cell lymphoma Untreated | Lymphoma transformation Untreated
Item
1. patients must have newly diagnosed, previously untreated diffuse large b-cell lymphoma, mantle cell lymphoma, grade 3b follicular lymphoma, burkitt lymphoma, peripheral t cell lymphoma nos, nk/t cell lymphoma, or transformed lymphoma.
boolean
C0079744 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0334634 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
C0024301 (UMLS CUI [3,1])
C0441800 (UMLS CUI [3,2])
C0332155 (UMLS CUI [3,3])
C0006413 (UMLS CUI [4,1])
C0332155 (UMLS CUI [4,2])
C0079774 (UMLS CUI [5,1])
C0332155 (UMLS CUI [5,2])
C0558916 (UMLS CUI [6,1])
C0332155 (UMLS CUI [6,2])
C0024299 (UMLS CUI [7,1])
C0040682 (UMLS CUI [7,2])
C0332155 (UMLS CUI [7,3])
Chemotherapy cycle Quantity Planned | pegfilgrastim | Risk Febrile Neutropenia Diminishing | R-CHOP chemotherapy regimen | R-EPOCH Regimen | Other Coding | CHOP regimen | Other Coding
Item
2. planned to receive chemotherapy for 6 cycles which the treating physician plans to utilize for pegfilgrastim to minimize risk for neutropenic fever, including but not limited to r-chop, r-epoch, and r-hypercvad, chop, and smile.
boolean
C1302181 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1301732 (UMLS CUI [1,3])
C1136535 (UMLS CUI [2])
C0035647 (UMLS CUI [3,1])
C0746883 (UMLS CUI [3,2])
C0205216 (UMLS CUI [3,3])
C4302501 (UMLS CUI [4])
C1882521 (UMLS CUI [5])
C3846158 (UMLS CUI [6])
C0163868 (UMLS CUI [7])
C3846158 (UMLS CUI [8])
Age
Item
3. age >= 18 years old.
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
4. ecog performance status 0-3.
boolean
C1520224 (UMLS CUI [1])
Informed Consent
Item
5. ability to provide informed consent for participation.
boolean
C0021430 (UMLS CUI [1])
Bone pain chronic | Status pre- Use of Pegfilgrastim
Item
1. existing chronic bone pain prior to pegfilgrastim usage.
boolean
C0151825 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
C0332152 (UMLS CUI [2,1])
C1524063 (UMLS CUI [2,2])
C1136535 (UMLS CUI [2,3])
Estimation of creatinine clearance by Cockcroft-Gault formula
Item
2. creatinine clearance of <50ml/minute by cockcroft gault equation.
boolean
C2711451 (UMLS CUI [1])
Filgrastim allergy | Hypersensitivity Pegfilgrastim | Loratadine allergy
Item
3. allergy to filgrastim, pegfilgrastim, or loratadine.
boolean
C0570660 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C1136535 (UMLS CUI [2,2])
C0571031 (UMLS CUI [3])
Antihistamines Used daily chronic | Pharmaceutical Preparations Alternative Lacking
Item
4. chronic daily usage of antihistamine without an acceptable alternative non-antihistamine medication.
boolean
C0019590 (UMLS CUI [1,1])
C3845591 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C1523987 (UMLS CUI [2,2])
C0332268 (UMLS CUI [2,3])
Lacking Able to swallow Oral medication
Item
5. inability to swallow medications.
boolean
C0332268 (UMLS CUI [1,1])
C2712086 (UMLS CUI [1,2])
C0175795 (UMLS CUI [1,3])
Survey Completion Unable
Item
6. inability to complete the survey instrumentation accurately.
boolean
C0038951 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])